fbpx An update on Mmr | Page 201 | Science in the net

An update on Mmr

Primary tabs

Read time: 1 min

Measles, mumps and rubella outbreaks still represent an healthcare issue, even though major advancements have been done towards their eradication. A poor inclination towards Mmr (measles-mumps-rubella) vaccination may constitute a major cause of increased risk to contract one of these diseases amongst specific population groups like migrants, alternative medicine users, some religious groups, healthcare professionals.
Information on Mmr vaccines coverage amongst these and others “hard-to-reach” groups was included in a document made and published Ecdc in range of the European project Venice II (Vaccine European New Integrated Collaboration Effort II). Main aim of the document was to provide a complete review of measles, mumps and rubella focuses which have been reported in the last twenty years in Europe.

Autori: 
Sezioni: 
Indice: 
Vaccination

prossimo articolo

European and US research policies: which direction for 2014?

Some weeks ago, the European Union released the planned quotas of investment in research for 2014, the first year of the new-born Horizon 2020 program. At the same time, on January 13th the US Congress agreed on a budget, containing the American policy about investments in research. Thus, is it possible to predict in which directions EU and US research will go, by comparing these two draft budgets? Will these two policies merge or not?

Sources and methodology